MFSD2A and metabolic dysfunction-associated steatohepatitis: To provide an independent confirmation of these mRNA findings, we recruited 5 patients with NASH and 5 patients without NASH from Singapore General Hospital (Supplemental Table 1) and examined Mfsd2a protein expression using IHC in liver biopsies obtained in these patients.